These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6806660)

  • 1. Oxygen transport in vivo by means of perfluorochemical preparations.
    Geyer RP
    N Engl J Med; 1982 Jul; 307(5):304-5. PubMed ID: 6806660
    [No Abstract]   [Full Text] [Related]  

  • 2. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
    Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
    N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of perfluorochemicals in the treatment of acute cerebral ischemia.
    Peerless SJ
    Prog Clin Biol Res; 1983; 122():353-62. PubMed ID: 6410404
    [No Abstract]   [Full Text] [Related]  

  • 5. Normothermic whole body rinse-out utilizing perfluorochemical(PFC)-containing artificial blood.
    Agishi T; Yamagata K; Kobayashi M; Teraoka S; Honda H; Ota K
    Trans Am Soc Artif Intern Organs; 1984; 30():295-7. PubMed ID: 6533899
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%.
    Tremper KK
    Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood substitutes as therapy in massive surgery and trauma.
    Tye RW
    Prog Clin Biol Res; 1982; 108():79-89. PubMed ID: 6817339
    [No Abstract]   [Full Text] [Related]  

  • 9. [Perfluorochemicals as artificial blood. problems and actual development (author's transl)].
    Schnoy N; Pfannkuch F; Beisbarth H
    Anaesthesist; 1979 Nov; 28(11):503-10. PubMed ID: 118676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluorocarbons as possible oxygen-carrying blood substitutes].
    Afonin NI; Doronina NN
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):41-5. PubMed ID: 7220520
    [No Abstract]   [Full Text] [Related]  

  • 11. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
    Kessler M; Vogel H; Günther H; Harrison DK; Höper J
    Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
    [No Abstract]   [Full Text] [Related]  

  • 12. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes.
    Bolin RB
    Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological study and clinical application of fluorocarbon artificial blood].
    Zhang RA; Xiong RC; Su BJ
    Zhonghua Wai Ke Za Zhi; 1985 Jul; 23(7):395-8, 443-4. PubMed ID: 4053861
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
    Handa H; Nagasawa S; Yonekawa Y; Naruo Y; Oda Y
    Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of blood substitutes].
    Ohyanagi H; Saitoh Y; Mitsuno T
    Nihon Rinsho; 1980; 38(4):1966-79. PubMed ID: 6447815
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
    Madjidi A; Beisbarth H; Frey R
    Prog Clin Biol Res; 1983; 122():391-7. PubMed ID: 6192451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.